- UroToday Home
- Urologic Oncology
The Latest Bladder Cancer Research
Recent Abstracts
-
New Research Has Found That Women More Likely to Face Bladder Cancer Diagnosis Delays than MenBladder CancerMay 7, 2021
-
RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.Bladder CancerMay 7, 2021
-
Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer.Bladder CancerMay 7, 2021
-
Avelumab for Use as a Bladder Cancer Maintenance Treatment Not Recommended by NHS in EnglandBladder CancerMay 6, 2021
-
Implications of Guideline-based, Risk-stratified Restaging Transurethral Resection of High-grade Ta Urothelial Carcinoma on Bacillus Calmette-Guérin Therapy Outcomes.Bladder CancerMay 6, 2021
-
Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer.Bladder CancerMay 6, 2021
-
Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice.Bladder CancerMay 5, 2021
-
PD-L1 expression in urothelial bladder cancer varies more among specimen types than between companion assays.Bladder CancerMay 5, 2021
-
Stereotactic Body Radiotherapy for Palliation of Hematuria Arising From Urothelial Carcinoma of the Kidney in Unfavorable Surgical CandidatesBladder CancerMay 4, 2021
-
Clinical use of machine learning-based patho-mics signature for diagnosis and survival prediction of bladder cancer.Bladder CancerMay 4, 2021
Beyond the Abstracts
-
Heated Intravesical Chemotherapy: Biology and Clinical Utility - Beyond the AbstractBladder CancerApril 29, 2021
-
Defining Cisplatin Eligibility in Patients with Muscle-Invasive Bladder Cancer - Beyond the AbstractBladder CancerApril 14, 2021
-
Clinical Trial of High Dose Hyperthermic Intravesical Mitomycin C for Intermediate and High-Risk Non-Muscle Invasive Bladder Cancer During BCG Shortage - Beyond the AbstractBladder CancerApril 1, 2021
-
A Review of Adaptive Radiotherapy for Bladder Cancer - Beyond the AbstractBladder CancerMarch 31, 2021
-
Adjuvant Radiotherapy After Radical Cystectomy for Muscle-Invasive Bladder Cancer - Beyond the AbstractBladder CancerMarch 26, 2021
-
Investigating the Association Between the Urinary Microbiome and Bladder Cancer: An Exploratory Study - Beyond the AbstractBladder CancerMarch 23, 2021
-
Treatment of Large Non-Muscle-Invasive Bladder Cancer: The Potential Role of Neoadjuvant Intravesical Chemotherapy - Beyond the AbstractBladder CancerMarch 5, 2021
-
Midterm Follow-up (3 Years) Confirms and Extends Short-Term Results of Intravesical Gemcitabine as Bladder-Preserving Treatment for Non-Muscle-Invasive Bladder Cancer After BCG Failure - Beyond the AbstractBladder CancerFebruary 24, 2021
-
Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer - Beyond the AbstractBladder CancerFebruary 9, 2021
-
Bladder Tumor Subtype Commitment Occurs in Carcinoma In-Situ Driven by Key Signaling Pathways Including ECM Remodeling - Beyond the AbstractBladder CancerFebruary 3, 2021